GG 366 (Benazepril hydrochloride and hydrochlorothiazide 20 mg / 12.5 mg)

Pill imprint GG 366 has been identified as Benazepril hydrochloride and hydrochlorothiazide 20 mg / 12.5 mg.

Benazepril is used in the treatment of diabetic kidney disease; high blood pressure; left ventricular dysfunction; heart failure and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Benazepril 20 mg / 12.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Benazepril hydrochloride and hydrochlorothiazide

Imprint:

GG 366

Strength:

20 mg / 12.5 mg

Color:

Purple

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Angiotensin converting enzyme inhibitors

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Manufacturer:

Sandoz Pharmaceuticals Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.